Skip to main content
Clinical Trials/NCT05446649
NCT05446649
Unknown
Not Applicable

Dry Needling Versus Instrumented Assisted Soft Tissue Mobilization In the Patient With Cervicogenic Treatment Headache; Randomized Controlled Trial

Cairo University1 site in 1 country60 target enrollmentJuly 5, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervicogenic Headache
Sponsor
Cairo University
Enrollment
60
Locations
1
Primary Endpoint
pressure pain threshold
Last Updated
3 years ago

Overview

Brief Summary

the aim of this study is to investigate the efficacy of Dry Needling Versus Instrumented Assisted Soft Tissue Mobilization In the Patient With Cervicogenic Treatment Headache

Detailed Description

Cervicogenic headache has been classified as a secondary type headache, and it is usually associated with cervical myofascial pain sources as myofascial trigger points . It also could be related to any joint, disc, and ligament disease of the upper region of the neck.physiotherapist use trigger point dry needling as an invasive treatment for CGH where a solid filament needle is inserted into a myofascial trigger point . The advantages of Dry needling are increasingly documented .Instrument-assisted soft tissue mobilization technique has been reported to decrease pain, improve overall function, and increase range of motion . It enhances the ability of physical therapists to detect altered tissue properties, through the vibration sense within the instrument, and to treat soft tissue dysfunction. It also enhances the patient's awareness of altered sensations within the treated tissues.

Registry
clinicaltrials.gov
Start Date
July 5, 2022
End Date
October 30, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Al Shaymaa Shaaban Abd El Azeim

principal investigator

Cairo University

Eligibility Criteria

Inclusion Criteria

  • 20 to 60 years old patient with unilaterally of the head pain
  • pain triggered by external pressure over the upper cervical joints (c1-c3)
  • pain elicited by the neck movements, and/or sustained awkward positions with reduced neck ROM
  • headache intensity pain score of at least 20mm on the Visual analogue scale (VAS)
  • headache frequency of at least once a week for at least 3 months
  • minimum neck disability index score of 10 points or greater

Exclusion Criteria

  • Migraine, tension- type headache, tumor, osteoporosis, fracture, rheumatoid arthritis and metabolic diseases.
  • Prolonged history of steroid use.
  • Resting blood pressure greater than 140/90 mmhg.
  • cervical spinal stenosis, diminished sensation and central nervous system involvement,
  • previous head or neck surgery or whiplash injury history within the last 6 weeks

Outcomes

Primary Outcomes

pressure pain threshold

Time Frame: up to four weeks

pressure pain threshold will be assessed by commander algometer

pain intensity

Time Frame: up to four weeks

visual analogue scale will be used to asses pain intensity which patient will be instructed to put point on line from no pain to tolerable pain. The scale consists of a line, usually 10 cm long, ranging from no pain or discomfort (zero) , to the worst pain that could possibly feel .

neck disability

Time Frame: up to four weeks

will be measured by Arabic neck disability index. It contains ten category/classes. Each category contains six choices (zero-five).Score from zero to four no disability, from five to 15 this is mild, From 15 to 24 this is moderate, from 25 to 34 this is severe, more than 34 this is a complete disability

Secondary Outcomes

  • medication intake(up to four weeks)
  • range of motion(up to four weeks)
  • headache frequency(up to four weeks)
  • headache duration(up to four weeks)

Study Sites (1)

Loading locations...

Similar Trials